These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24892810)

  • 1. Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals.
    Kardava L; Moir S; Shah N; Wang W; Wilson R; Buckner CM; Santich BH; Kim LJ; Spurlin EE; Nelson AK; Wheatley AK; Harvey CJ; McDermott AB; Wucherpfennig KW; Chun TW; Tsang JS; Li Y; Fauci AS
    J Clin Invest; 2014 Jul; 124(7):3252-62. PubMed ID: 24892810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.
    Scheid JF; Mouquet H; Feldhahn N; Seaman MS; Velinzon K; Pietzsch J; Ott RG; Anthony RM; Zebroski H; Hurley A; Phogat A; Chakrabarti B; Li Y; Connors M; Pereyra F; Walker BD; Wardemann H; Ho D; Wyatt RT; Mascola JR; Ravetch JV; Nussenzweig MC
    Nature; 2009 Apr; 458(7238):636-40. PubMed ID: 19287373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals.
    Montezuma-Rusca JM; Moir S; Kardava L; Buckner CM; Louie A; Kim LJ; Santich BH; Wang W; Fankuchen OR; Diaz G; Daub JR; Rosenzweig SD; Chun TW; Li Y; Braylan RC; Calvo KR; Fauci AS
    J Immunol; 2015 Mar; 194(6):2561-8. PubMed ID: 25681347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection.
    Bonsignori M; Moody MA; Parks RJ; Holl TM; Kelsoe G; Hicks CB; Vandergrift N; Tomaras GD; Haynes BF
    J Immunol; 2009 Aug; 183(4):2708-17. PubMed ID: 19625640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses.
    Mouquet H; Klein F; Scheid JF; Warncke M; Pietzsch J; Oliveira TY; Velinzon K; Seaman MS; Nussenzweig MC
    PLoS One; 2011; 6(9):e24078. PubMed ID: 21931643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT; Glenn JA; Lippy A; Stamatatos L
    J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins.
    Li Y; O'Dell S; Wilson R; Wu X; Schmidt SD; Hogerkorp CM; Louder MK; Longo NS; Poulsen C; Guenaga J; Chakrabarti BK; Doria-Rose N; Roederer M; Connors M; Mascola JR; Wyatt RT
    J Virol; 2012 Oct; 86(20):11231-41. PubMed ID: 22875963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction.
    Brocca-Cofano E; Kuhrt D; Siewe B; Xu C; Haret-Richter GS; Craigo J; Labranche C; Montefiori DC; Landay A; Apetrei C; Pandrea I
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of cross-neutralizing antibody specificities to the CD4-BS and the carbohydrate cloak of the HIV Env in an HIV-1-infected subject.
    Mikell I; Stamatatos L
    PLoS One; 2012; 7(11):e49610. PubMed ID: 23152926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
    Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Neutralizing Antibodies in HIV-1 Patients on Antiretroviral Treatment for Over Ten Years.
    Cao W; Wang X; Li B; Lin L; Du Z; Zhao H; Zhang Y; Xu Z; Qiao Y
    Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of cross-neutralizing antibodies and mapping epitope specificity in plasma of chronic HIV-1-infected antiretroviral therapy-naïve children from India.
    Makhdoomi MA; Khan L; Kumar S; Aggarwal H; Singh R; Lodha R; Singla M; Das BK; Kabra SK; Luthra K
    J Gen Virol; 2017 Jul; 98(7):1879-1891. PubMed ID: 28696188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient neutralization by plasma antibodies from human immunodeficiency virus type-1 infected individuals on antiretroviral drug therapy.
    Andrabi R; Makhdoomi MA; Kumar R; Bala M; Parray H; Gupta A; Kotnala A; Thirumurthy V; Luthra K
    J Clin Immunol; 2014 May; 34(4):504-13. PubMed ID: 24682667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140.
    Stamatos NM; Mascola JR; Kalyanaraman VS; Louder MK; Frampton LM; Birx DL; VanCott TC
    J Virol; 1998 Dec; 72(12):9656-67. PubMed ID: 9811699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.
    Amos JD; Himes JE; Armand L; Gurley TC; Martinez DR; Colvin L; Beck K; Overman RG; Liao HX; Moody MA; Permar SR
    J Virol; 2015 Sep; 89(18):9485-98. PubMed ID: 26157116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity.
    Kobie JJ; Alcena DC; Zheng B; Bryk P; Mattiacio JL; Brewer M; Labranche C; Young FM; Dewhurst S; Montefiori DC; Rosenberg AF; Feng C; Jin X; Keefer MC; Sanz I
    PLoS One; 2012; 7(4):e35356. PubMed ID: 22530008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals.
    Moir S; Ho J; Malaspina A; Wang W; DiPoto AC; O'Shea MA; Roby G; Kottilil S; Arthos J; Proschan MA; Chun TW; Fauci AS
    J Exp Med; 2008 Aug; 205(8):1797-805. PubMed ID: 18625747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.